Litigation Details for SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)
✉ Email this page to a colleague
SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)
Docket | ⤷ Try a Trial | Date Filed | 2017-07-06 |
Court | District Court, D. New Jersey | Date Terminated | 2022-07-31 |
Cause | 15:1126 Patent Infringement | Assigned To | Claire Claudia Cecchi |
Jury Demand | Plaintiff | Referred To | Mark Falk |
Parties | HUAHAI US INC. | ||
Patents | 10,030,060; 6,063,927; 6,080,759; 6,113,944; 6,172,233; 7,598,271; 8,658,663; 8,946,251; 9,375,388; 9,393,237 | ||
Attorneys | JOHN COLEMAN LIFLAND | ||
Firms | Jams | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC.
Biologic Drugs cited in SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC.
Details for SEBELA INTERNATIONAL LIMITED v. PRINSTON PHARMACEUTICAL, INC. (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-07-06 | 1 | Label (April 2017), # 2 Exhibit B: U.S. Patent No. 9,393,237, # 3 Exhibit C: Actavis ANDA Approved Labeling…2017 31 July 2022 2:17-cv-04964 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff | External link to document | |
2017-07-08 | 10 | U.S. Patent No. 9,393,237, # 4 Exhibit 3: U.S. Patent No. 8,658,663, # 5 Exhibit 4: U.S. Patent No. 8,946,251…2017 31 July 2022 2:17-cv-04964 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff | External link to document | |
2017-07-10 | 11 | HOLDER or l'ATENT OR TRADEMARK. I us 9,393,237 7/19/2016 … ~ 0 Trademarks or ~Patents. ( O the patent action involves 35 U.S.C. § 292.): DOCKET… AO120 Patent Form filed. (jr) (Entered: 07/10/2017) 10 July 2017 PACER Document … REPORT ON THE Director of the U.S. Patent and Trademark Office … ACTION REGARDING A PATENT OR Alexandria, VA 22313 | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |